Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Oct;116(3):2048–2052. doi: 10.1111/j.1476-5381.1995.tb16410.x

Reflex circulatory collapse following intrapulmonary entrapment of activated platelets: mediation via 5-HT3 receptor stimulation.

O L Leaños 1, E Hong 1, J L Amezcua 1
PMCID: PMC1908951  PMID: 8640344

Abstract

1. The role of 5-HT2 and 5-HT3 receptors in the mediation of direct and reflex vascular responses to intrapulmonary platelet activation was investigated. 2. Anaesthetized rabbits were challenged intravenously with an emulsion of autologous bone marrow that produced a sharp increase in pulmonary blood pressure, a fall in systemic blood pressure, platelet consumption and death. 3. Platelet depletion before the challenge nearly abolished all the cardiovascular effects and prevented death. Bilateral vagotomy prevented the fall in systemic blood pressure and death but did no prevent the increase in pulmonary pressure. The intravenous administration of the 5-HT2 antagonist, ketanserin, only reduced the increase in pulmonary pressure without affecting the systemic response or mortality. 4. The effects of intravenous 5-HT and of electrical stimulation of the cephalic ends of the cut vagi nerves were also explored. 5-HT injection increased the pulmonary vascular pressure but its effects on systemic blood pressure were variable. These response were modified by the 5-HT antagonists in a manner that resembles their effects on bone marrow embolism. Afferent vagal stimulation produced a fall in systemic blood pressure that was not prevented by MDL-7222. 5. This study indicates that a centrally mediated reduction of peripheral vascular tone is the cause of the potentially lethal circulatory collapse that follows the intrapulmonary entrapment of activated platelets. This reflex is initiated by the action of 5-HT on 5-HT3 receptors in the lung.

Full text

PDF
2048

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P., Middlemiss D. N., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986 Jun;25(6):563–576. doi: 10.1016/0028-3908(86)90207-8. [DOI] [PubMed] [Google Scholar]
  2. COMROE J. H., Jr, VAN LINGEN B., STROUD R. C., RONCORONI A. Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis. Am J Physiol. 1953 Jun;173(3):379–386. doi: 10.1152/ajplegacy.1953.173.3.379. [DOI] [PubMed] [Google Scholar]
  3. Fozard J. R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):36–44. doi: 10.1007/BF00518776. [DOI] [PubMed] [Google Scholar]
  4. Gossling H. R., Pellegrini V. D., Jr Fat embolism syndrome: a review of the pathophysiology and physiological basis of treatment. Clin Orthop Relat Res. 1982 May;(165):68–82. [PubMed] [Google Scholar]
  5. Gurewich V., Cohen M. L., Thomas D. P. Humoral factors in massive pulmonary embolism: an experimental study. Am Heart J. 1968 Dec;76(6):784–794. doi: 10.1016/0002-8703(68)90264-0. [DOI] [PubMed] [Google Scholar]
  6. Hechtman H. B., Lonergan E. A., Staunton H. P., Dennis R. C., Shepro D. Pulmonary entrapment of platelets during acute respiratory failure. Surgery. 1978 Mar;83(3):277–283. [PubMed] [Google Scholar]
  7. Junod A. F. Metabolism of the intact pulmonary microcirculation. Ann N Y Acad Sci. 1982;384:66–71. doi: 10.1111/j.1749-6632.1982.tb21363.x. [DOI] [PubMed] [Google Scholar]
  8. Moylan J. A., Birnbaum M., Katz A., Everson M. A. Fat emboli syndrome. J Trauma. 1976 May;16(5):341–347. doi: 10.1097/00005373-197605000-00002. [DOI] [PubMed] [Google Scholar]
  9. Peltier L. F. Fat embolism. An appraisal of the problem. Clin Orthop Relat Res. 1984 Jul-Aug;(187):3–17. [PubMed] [Google Scholar]
  10. Quinn J. L., 3rd, Ciric I., Hauser W. N. Analysis of 96 abnormal brain scans using technetium 99m (pertechnetate form). JAMA. 1965 Oct 11;194(2):157–160. [PubMed] [Google Scholar]
  11. ROBB H. J. THE ROLE OF MICRO-EMBOLISM IN THE PRODUCTION OF IRREVERSIBLE SHOCK. Ann Surg. 1963 Oct;158:685–697. doi: 10.1097/00000658-196310000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rivkind A. I., Siegel J. H., Guadalupi P., Littleton M. Sequential patterns of eicosanoid, platelet, and neutrophil interactions in the evolution of the fulminant post-traumatic adult respiratory distress syndrome. Ann Surg. 1989 Sep;210(3):355–373. doi: 10.1097/00000658-198909000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Saldeen T. Trends in microvascular research. The microembolism syndrome. Microvasc Res. 1976 Mar;11(2):227–259. doi: 10.1016/0026-2862(76)90054-6. [DOI] [PubMed] [Google Scholar]
  14. Svensson J., Fredholm B. B. Vasoconstrictor effect of thromboxane A2. Acta Physiol Scand. 1977 Nov;101(3):366–368. doi: 10.1111/j.1748-1716.1977.tb06019.x. [DOI] [PubMed] [Google Scholar]
  15. Thorén P. Role of cardiac vagal C-fibers in cardiovascular control. Rev Physiol Biochem Pharmacol. 1979;86:1–94. doi: 10.1007/BFb0031531. [DOI] [PubMed] [Google Scholar]
  16. VAN LOGHEM JJ J., DORFMEIJER H., VAN HART M., SCHREUDER F. Serological and genetical studies on a platelet antigen (Zw). Vox Sang. 1959 Apr;4(2):161–169. doi: 10.1111/j.1423-0410.1959.tb04032.x. [DOI] [PubMed] [Google Scholar]
  17. Vaage J. Intravascular platelet aggregation and pulmonary injury. Ann N Y Acad Sci. 1982;384:301–318. doi: 10.1111/j.1749-6632.1982.tb21380.x. [DOI] [PubMed] [Google Scholar]
  18. Vandeplassche G., Hermans C., Van Dael L., Wouters L., De Clerck F. Interplay between platelet-derived 5-hydroxytryptamine and arachidonic acid metabolites limits the thrombolytic efficacy of streptokinase against canine platelet-rich coronary thrombosis. J Cardiovasc Pharmacol. 1993 Jan;21(1):56–69. doi: 10.1097/00005344-199301000-00009. [DOI] [PubMed] [Google Scholar]
  19. Vane J. R. The release and fate of vaso-active hormones in the circulation. Br J Pharmacol. 1969 Feb;35(2):209–242. doi: 10.1111/j.1476-5381.1969.tb07982.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES